Načítá se...
IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity
Indoleamine 2,3-dioxygenase 2 (IDO2), a homolog of the better-studied tryptophan-catabolizing enzyme IDO1, is an immunomodulatory molecule with potential effects on various diseases including cancer and autoimmunity. Here, we review what is known about the direct connections between IDO2 and immune...
Uloženo v:
| Vydáno v: | Clin Med Insights Pathol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Libertas Academica
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5119657/ https://ncbi.nlm.nih.gov/pubmed/27891058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CPath.S39930 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|